MicroRNAs

Novel mediators of resistance to microtubule-targeting agents

Arun Kanakkanthara, John H. Miller

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that act as expression regulators of genes involved in diverse cellular processes, including cell proliferation, differentiation, and apoptosis. Abnormal expression of miRNAs can have profound effects on cellular function, and miRNAs are implicated in tumourigenesis either as oncogenes or tumour suppressors. Deregulated miRNAs have been shown to have a role in the resistance of cancer cells to microtubule-targeting agents (MTAs). Here, we discuss how altered expression of miRNAs mediates resistance to clinically useful MTAs, such as paclitaxel and vincristine. Understanding the molecular role of miRNAs in drug resistance would help improve therapeutic efficacy of these agents by helping circumvent the problem of drug resistance.

Original languageEnglish (US)
Pages (from-to)161-170
Number of pages10
JournalCancer Treatment Reviews
Volume39
Issue number2
DOIs
StatePublished - Apr 1 2013
Externally publishedYes

Fingerprint

MicroRNAs
Microtubules
Drug Resistance
Small Untranslated RNA
Vincristine
Regulator Genes
Paclitaxel
Oncogenes
Cell Differentiation
Neoplasms
Cell Proliferation
Apoptosis

Keywords

  • Cancer cells
  • Drug resistance
  • MicroRNAs
  • Microtubule-targeting agents

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

MicroRNAs : Novel mediators of resistance to microtubule-targeting agents. / Kanakkanthara, Arun; Miller, John H.

In: Cancer Treatment Reviews, Vol. 39, No. 2, 01.04.2013, p. 161-170.

Research output: Contribution to journalReview article

@article{f39d3b6d79bd44e199e2ad3f29426e25,
title = "MicroRNAs: Novel mediators of resistance to microtubule-targeting agents",
abstract = "MicroRNAs (miRNAs) are small, non-coding RNAs that act as expression regulators of genes involved in diverse cellular processes, including cell proliferation, differentiation, and apoptosis. Abnormal expression of miRNAs can have profound effects on cellular function, and miRNAs are implicated in tumourigenesis either as oncogenes or tumour suppressors. Deregulated miRNAs have been shown to have a role in the resistance of cancer cells to microtubule-targeting agents (MTAs). Here, we discuss how altered expression of miRNAs mediates resistance to clinically useful MTAs, such as paclitaxel and vincristine. Understanding the molecular role of miRNAs in drug resistance would help improve therapeutic efficacy of these agents by helping circumvent the problem of drug resistance.",
keywords = "Cancer cells, Drug resistance, MicroRNAs, Microtubule-targeting agents",
author = "Arun Kanakkanthara and Miller, {John H.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.ctrv.2012.07.005",
language = "English (US)",
volume = "39",
pages = "161--170",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - MicroRNAs

T2 - Novel mediators of resistance to microtubule-targeting agents

AU - Kanakkanthara, Arun

AU - Miller, John H.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - MicroRNAs (miRNAs) are small, non-coding RNAs that act as expression regulators of genes involved in diverse cellular processes, including cell proliferation, differentiation, and apoptosis. Abnormal expression of miRNAs can have profound effects on cellular function, and miRNAs are implicated in tumourigenesis either as oncogenes or tumour suppressors. Deregulated miRNAs have been shown to have a role in the resistance of cancer cells to microtubule-targeting agents (MTAs). Here, we discuss how altered expression of miRNAs mediates resistance to clinically useful MTAs, such as paclitaxel and vincristine. Understanding the molecular role of miRNAs in drug resistance would help improve therapeutic efficacy of these agents by helping circumvent the problem of drug resistance.

AB - MicroRNAs (miRNAs) are small, non-coding RNAs that act as expression regulators of genes involved in diverse cellular processes, including cell proliferation, differentiation, and apoptosis. Abnormal expression of miRNAs can have profound effects on cellular function, and miRNAs are implicated in tumourigenesis either as oncogenes or tumour suppressors. Deregulated miRNAs have been shown to have a role in the resistance of cancer cells to microtubule-targeting agents (MTAs). Here, we discuss how altered expression of miRNAs mediates resistance to clinically useful MTAs, such as paclitaxel and vincristine. Understanding the molecular role of miRNAs in drug resistance would help improve therapeutic efficacy of these agents by helping circumvent the problem of drug resistance.

KW - Cancer cells

KW - Drug resistance

KW - MicroRNAs

KW - Microtubule-targeting agents

UR - http://www.scopus.com/inward/record.url?scp=84869488084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869488084&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2012.07.005

DO - 10.1016/j.ctrv.2012.07.005

M3 - Review article

VL - 39

SP - 161

EP - 170

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 2

ER -